PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
25.49
+0.28 (1.11%)
Apr 25, 2024, 4:00 PM EDT - Market closed
PTC Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 937.82 | 698.8 | 538.59 | 380.77 | 306.98 | 264.73 | 194.39 | 82.71 | 36.77 | 25.25 | Upgrade
|
| Revenue Growth (YoY) | 34.20% | 29.75% | 41.45% | 24.04% | 15.96% | 36.19% | 135.04% | 124.95% | 45.64% | -27.24% | Upgrade
|
| Cost of Revenue | 65.49 | 44.68 | 32.33 | 18.94 | 12.14 | 12.67 | 4.58 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | 872.34 | 654.12 | 506.27 | 361.82 | 294.85 | 252.06 | 189.82 | 82.71 | 36.77 | 25.25 | Upgrade
|
| Selling, General & Admin | 332.54 | 326 | 285.77 | 245.16 | 202.54 | 153.55 | 121.27 | 97.13 | 82.08 | 44.82 | Upgrade
|
| Research & Development | 666.56 | 651.5 | 540.68 | 477.64 | 257.45 | 171.98 | 117.46 | 117.63 | 121.82 | 79.84 | Upgrade
|
| Other Operating Expenses | 440.44 | 149.94 | 54.75 | 47.51 | 27.65 | 22.88 | 15.38 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 1,440 | 1,127 | 881.21 | 770.31 | 487.64 | 348.41 | 254.11 | 214.76 | 203.9 | 124.66 | Upgrade
|
| Operating Income | -567.2 | -473.31 | -374.94 | -408.49 | -192.8 | -96.35 | -64.29 | -132.06 | -167.13 | -99.41 | Upgrade
|
| Interest Expense / Income | 129.18 | 90.87 | 86.02 | 56.35 | 12.49 | 12.55 | 12.09 | 8.28 | 2.37 | -1.18 | Upgrade
|
| Other Expense / Income | -0.27 | 23.31 | 57.38 | -61.91 | 34.64 | 19.21 | 1.28 | 1.21 | 0.47 | 0.21 | Upgrade
|
| Pretax Income | -696.11 | -587.49 | -518.34 | -402.93 | -239.93 | -128.11 | -77.67 | -141.54 | -169.96 | -98.45 | Upgrade
|
| Income Tax | -69.51 | -28.47 | 5.56 | 35.23 | 11.65 | -0.03 | 1.34 | 0.57 | 0.49 | -4.69 | Upgrade
|
| Net Income | -626.6 | -559.02 | -523.9 | -438.16 | -251.58 | -128.08 | -79 | -142.11 | -170.45 | -93.75 | Upgrade
|
| Shares Outstanding (Basic) | 75 | 72 | 70 | 66 | 59 | 47 | 39 | 34 | 34 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 75 | 72 | 70 | 66 | 59 | 47 | 39 | 34 | 34 | 32 | Upgrade
|
| Shares Change | 4.34% | 1.79% | 6.72% | 12.17% | 26.38% | 18.87% | 15.09% | 1.24% | 6.53% | 146.04% | Upgrade
|
| EPS (Basic) | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 | -5.07 | -2.97 | Upgrade
|
| EPS (Diluted) | -8.37 | -7.79 | -7.43 | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 | -5.07 | -2.97 | Upgrade
|
| Free Cash Flow | -186.86 | -388.67 | -279.55 | -211.91 | -112.4 | -34.74 | -13.16 | -105.34 | -127.06 | -61.94 | Upgrade
|
| Free Cash Flow Per Share | -2.50 | -5.42 | -3.97 | -3.21 | -1.91 | -0.75 | -0.34 | -3.09 | -3.78 | -1.96 | Upgrade
|
| Gross Margin | 93.02% | 93.61% | 94.00% | 95.03% | 96.05% | 95.21% | 97.65% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -60.48% | -67.73% | -69.62% | -107.28% | -62.80% | -36.39% | -33.07% | -159.67% | -454.58% | -393.79% | Upgrade
|
| Profit Margin | -66.81% | -80.00% | -97.27% | -115.07% | -81.95% | -48.38% | -40.64% | -171.83% | -463.60% | -371.37% | Upgrade
|
| Free Cash Flow Margin | -19.92% | -55.62% | -51.90% | -55.65% | -36.61% | -13.12% | -6.77% | -127.37% | -345.58% | -245.35% | Upgrade
|
| EBITDA | -320.51 | -357.9 | -360.8 | -255.62 | -191.55 | -89.47 | -47.89 | -129.98 | -164.72 | -97.39 | Upgrade
|
| EBITDA Margin | -34.18% | -51.22% | -66.99% | -67.13% | -62.40% | -33.80% | -24.64% | -157.15% | -448.02% | -385.78% | Upgrade
|
| Depreciation & Amortization | 246.42 | 138.72 | 71.52 | 90.96 | 35.89 | 26.09 | 17.68 | 3.29 | 2.88 | 2.24 | Upgrade
|
| EBIT | -566.93 | -496.62 | -432.32 | -346.58 | -227.44 | -115.56 | -65.57 | -133.27 | -167.6 | -99.63 | Upgrade
|
| EBIT Margin | -60.45% | -71.07% | -80.27% | -91.02% | -74.09% | -43.65% | -33.73% | -161.13% | -455.84% | -394.64% | Upgrade
|